Loading publications…
The last 5 uploaded publications
Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification
Carla Montironi, Florian Castet, Philipp K. Haber, Roser Pinyol, Miguel Torres‐Martín, Laura Torrens, Agavni Mesropian, Huan Wang, Marc Puigvehí, Miho Maeda, Wei Qiang Leow, Elizabeth Harrod, Patricia Taik, Jigjidsuren Chinburen, Erdenebileg Taivanbaatar, Chinbold Enkhbold, M. Solé Arqués, Michael Donovan, Swan N. Thung, Jaclyn Neely, Vincenzo Mazzaferro, Jeffrey Anderson, Sasan Roayaie, Myron Schwartz, Augusto Villanueva, Scott L. Friedman, Andrew Uzilov, Daniela Sia, Josep M. Llovet (2022). Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification. Gut, 72(1), pp. 129-140, DOI: 10.1136/gutjnl-2021-325918.
Article145 days agoImmunomodulatory Effects of Lenvatinib Plus Anti–Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma
Laura Torrens, Carla Montironi, Marc Puigvehí, Agavni Mesropian, Jack Leslie, Philipp K. Haber, Miho Maeda, Ugne Balaseviciute, Catherine E. Willoughby, Jordi Abril‐Fornaguera, Marta Piqué‐Gili, Miguel Torres‐Martín, Judit Peix, Daniel Geh, Erik Ramón-Gil, Behnam Saberi, Scott L. Friedman, Derek A. Mann, Daniela Sia, Josep M. Llovet (2021). Immunomodulatory Effects of Lenvatinib Plus Anti–Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma. Hepatology, 74(5), pp. 2652-2669, DOI: 10.1002/hep.32023.
Article145 days agoMixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity
Agrin Moeini, Daniela Sia, Zhongyang Zhang, Genís Campreciós, Ashley Stueck, Hui Dong, Robert Montal, Laura Torrens, Iris Martinez-Quetglas, Maria Isabel Fiel, Ke Hao, Augusto Villanueva, Swan N. Thung, Myron Schwartz, Josep M. Llovet (2017). Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity. Journal of Hepatology, 66(5), pp. 952-961, DOI: 10.1016/j.jhep.2017.01.010.
Article145 days agoEpigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications
Juan Carrillo-Reixach, Laura Torrens, Marina Simon‐Coma, Laura Royo, Montserrat Domingo-Sàbat, Jordi Abril‐Fornaguera, Nicholas K. Akers, María Sala, S. Ragull, Magdalena Arnal, Núria Villalmanzo, Stefano Cairo, Alberto Villanueva, Roland Kappler, Marta Garrido, Laura Guerra, Constantino Sábado, Gabriela Guillén, Mar Mallo, David Piñeyro, Maria Vázquez‐Vitali, Olga Kuchuk, María Elena Mateos, Gema Ramírez, Manuel Santamarı́a, Yasmina Mozo, Aroa Soriano, Michael Grotzer, Sophie Branchereau, Nagore García de Andoín, Blanca López‐Ibor, Ricardo López Almaraz, José Antonio Salinas, Bárbara Torres, F Hernández, José Javier Uriz, Monique Fabrè, Julià Blanco, Claudia Paris, Viera Bajčiová, Geneviève Laureys, Helena Masnou, Ariadna Clos, Cristina Beléndez, Catherine Guettier, Lauro Sumoy, Ramón Planas, Mireia Jordà, Lara Nonell, Piotr Czauderna, Bruce Morland, Daniela Sia, Bojan Losic, Marie Annick Buendia, Maria‐Rosa Sarrias, Josep M. Llovet, Carolina Armengol (2020). Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications. Journal of Hepatology, 73(2), pp. 328-341, DOI: 10.1016/j.jhep.2020.03.025.
Article145 days agoLiver Injury Increases the Incidence of HCC following AAV Gene Therapy in Mice
Dhwanil A. Dalwadi, Laura Torrens, Jordi Abril‐Fornaguera, Roser Pinyol, Catherine E. Willoughby, Jeffrey Posey, Josep M. Llovet, Christian Lanciault, David W. Russell, Markus Grompe, Willscott E. Naugler (2020). Liver Injury Increases the Incidence of HCC following AAV Gene Therapy in Mice. Molecular Therapy, 29(2), pp. 680-690, DOI: 10.1016/j.ymthe.2020.10.018.
Article145 days ago